封面
市場調查報告書
商品編碼
1417876

3D 生物列印人體組織市場報告:2030 年趨勢、預測與競爭分析

3D Bioprinted Human Tissue Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日期: | 出版商: Lucintel | 英文 150 - page report | 商品交期: 3個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

3D 生物列印人體組織趨勢與預測

到 2030 年,全球 3D 生物列印人體組織市場預計將達到 34 億美元,2024 年至 2030 年複合年成長率為 7.8%。該市場的主要促進因素是免疫細胞療法的日益普及、技術進步以及對客製化 3D 列印、組織工程和器官替代的需求不斷成長。全球3D生物列印人體組織市場的未來充滿希望,在組織工程、整容手術、藥物測試和開發以及食品測試市場方面存在機會。

3D 生物列印人體組織市場洞察

Lucintel 預測,由於臨床試驗應用的採用率不斷提高,藥物測試和開發預計將在預測期內呈現最高成長。

由於政府研發支出增加,預計北美將成為預測期內最大的地區。

常問問題

Q1.市場規模有多大?

A1. 到 2030 年,全球 3D 生物列印人體組織市場預計將達到 34 億美元。

Q2.市場成長預測如何?

A2. 2024年至2030年,全球3D生物列印人體組織市場預計將以7.8%的複合年成長率成長。

Q3.影響市場成長的主要促進因素有哪些?

A3. 該市場的主要驅動力是免疫細胞療法的日益成長、技術進步以及對客製化 3D 列印、組織工程和器官替代的需求不斷成長。

Q4.市場的主要細分市場是什麼?

A4. 3D生物列印人體組織市場前景廣闊,在組織工程、整容手術、藥物測試和開發以及食品測試市場方面都有機會。

Q5.市場上主要企業有哪些?

A5. 3D生物列印人體組織的主要企業如下。

  • Organovo
  • Stratasys
  • 3D Systems
  • SOLS Systems
  • Youbionic

Q6.未來最大的細分市場是什麼?

A6.Lucintel 預測,由於臨床試驗應用的採用率不斷提高,藥物測試和開發將在預測期內呈現最高成長。

Q7. 未來五年預計哪個地區將成為最大的市場?

A7. 由於政府研發支出增加,北美成為預測期內最大的地區。

Q8. 可以客製化報告嗎?

A8. 是的,Lucintel 提供 10% 的客製化服務,無需額外付費。

目錄

第1章執行摘要

第2章全球 3D 生物列印人體組織市場:市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢(2018-2023)與預測(2024-2030)
  • 全球3D生物列印人體組織市場趨勢(2018-2023)與預測(2024-2030)
  • 全球 3D 生物列印人體組織市場(按應用)
    • 人體組織工程
    • 整容手術
    • 藥物測試和開發
    • 食品檢驗
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球 3D 生物列印人體組織市場(按地區)
  • 北美3D生物列印人體組織市場
  • 歐洲3D生物列印人體組織市場
  • 亞太地區 3D 生物列印人體組織市場
  • 其他地區3D生物列印人體組織市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球 3D 生物列印人體組織市場成長機會(按應用)
    • 全球 3D 生物列印人體組織市場成長機會(按地區)
  • 全球3D生物列印人體組織市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 全球 3D 生物列印人體組織市場產能擴張
    • 全球3D生物列印人體組織市場的併購與合資企業
    • 認證和許可

第7章主要企業概況

  • Organovo
  • Stratasys
  • 3D Systems
  • SOLS Systems
  • Youbionic
簡介目錄

3D Bioprinted Human Tissue Trends and Forecast

The future of the global 3D bioprinted human tissue market looks promising with opportunities in the tissue engineering, cosmetic surgery, drug testing and development, and food testing markets. The global 3D bioprinted human tissue market is expected to reach an estimated $3.4 billion by 2030 with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing inclination towards immune cellular therapies, progress in technology, and rising demand for customized 3D printing, tissue engineering and organ replacement.

A more than 150-page report is developed to help in your business decisions.

3D Bioprinted Human Tissue by Segment

The study includes a forecast for the global 3D bioprinted human tissue by application and region.

3D Bioprinted Human Tissue Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Tissue Engineering
  • Cosmetic Surgery
  • Drug Testing and Development
  • Food Testing
  • Others

3D Bioprinted Human Tissue Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of 3D Bioprinted Human Tissue Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies 3D bioprinted human tissue companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the 3D bioprinted human tissue companies profiled in this report include-

  • Organovo
  • Stratasys
  • 3D Systems
  • SOLS Systems
  • Youbionic

3D Bioprinted Human Tissue Market Insights

Lucintel forecasts that drug testing and dvelopment is expected to witness the highest growth over the forecast period due to its increasing adoption in the clinical trial applications.

North America will reamin the largest region over the forecast period due to rising government R&D spending.

Features of the Global 3D Bioprinted Human Tissue Market

Market Size Estimates: 3D bioprinted human tissue market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: 3D bioprinted human tissue market size by application and region in terms of value ($B).

Regional Analysis: 3D bioprinted human tissue market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different applications and regions for the 3D bioprinted human tissue market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the 3D bioprinted human tissue market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the 3D bioprinted human tissue market size?

Answer: The global 3D bioprinted human tissue market is expected to reach an estimated $3.4 billion by 2030.

Q2. What is the growth forecast for 3D bioprinted human tissue market?

Answer: The global 3D bioprinted human tissue market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the 3D bioprinted human tissue market?

Answer: The major drivers for this market are increasing inclination towards immune cellular therapies, progress in technology, and rising demand for customized 3D printing, tissue engineering and organ replacement.

Q4. What are the major segments for 3D bioprinted human tissue market?

Answer: The future of the 3D bioprinted human tissue market looks promising with opportunities in the tissue engineering, cosmetic surgery, drug testing and development, and food testing markets.

Q5. Who are the key 3D bioprinted human tissue market companies?

Answer: Some of the key 3D bioprinted human tissue companies are as follows.

  • Organovo
  • Stratasys
  • 3D Systems
  • SOLS Systems
  • Youbionic

Q6. Which 3D bioprinted human tissue market segment will be the largest in future?

Answer: Lucintel forecasts that drug testing and dvelopment is expected to witness the highest growth over the forecast period due to its increasing adoption in the clinical trial applications.

Q7. In 3D bioprinted human tissue market, which region is expected to be the largest in next 5 years?

Answer: North America will reamin the largest region over the forecast period due to rising government R&D spending.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the 3D bioprinted human tissue market by application (tissue engineering, cosmetic surgery, drug testing and development, food testing, and others) and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global 3D Bioprinted Human Tissue Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global 3D Bioprinted Human Tissue Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global 3D Bioprinted Human Tissue Market by Application
    • 3.3.1: Tissue Engineering
    • 3.3.2: Cosmetic Surgery
    • 3.3.3: Drug Testing and Development
    • 3.3.4: Food Testing
    • 3.3.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global 3D Bioprinted Human Tissue Market by Region
  • 4.2: North American 3D Bioprinted Human Tissue Market
  • 4.3: European 3D Bioprinted Human Tissue Market
    • 4.3.1: European 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
  • 4.4: APAC 3D Bioprinted Human Tissue Market
    • 4.4.1: APAC 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others
  • 4.5: ROW 3D Bioprinted Human Tissue Market
    • 4.5.1: ROW 3D Bioprinted Human Tissue Market by Application: Tissue Engineering, Cosmetic Surgery, Drug Testing and Development, Food Testing, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global 3D Bioprinted Human Tissue Market by Application
    • 6.1.2: Growth Opportunities for the Global 3D Bioprinted Human Tissue Market by Region
  • 6.2: Emerging Trends in the Global 3D Bioprinted Human Tissue Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global 3D Bioprinted Human Tissue Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global 3D Bioprinted Human Tissue Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Organovo
  • 7.2: Stratasys
  • 7.3: 3D Systems
  • 7.4: SOLS Systems
  • 7.5: Youbionic